NEET-PG 2013 Practice Questions

Q: Esophagus is present in which mediastinum?

Posterior. ***Posterior*** - The **esophagus** is primarily located in the **posterior mediastinum**, where the bulk of its length (from T4/T5 to T10) traverses [2]. - It lies **posterior** to the **trachea** and **heart**, anterior to the vertebral column [2]. - For examination purposes, the esophagus is considered a **key structure of the posterior mediastinum** [2]. - Note: The uppermost part (cervical and upper thoracic) does pass through the superior mediastinum, but the majority lies in the posterior compartment. *Anterior* - The **anterior mediastinum** is a small space located between the **sternum** and the pericardium. - It primarily contains **connective tissue**, remnants of the thymus, lymph nodes, and the internal thoracic vessels [1]. - The esophagus does not traverse this compartment. *Middle* - The **middle mediastinum** is centrally located and prominently contains the **heart** and the roots of the great vessels [1]. - It also houses the **pericardium**, the main bronchi, and the phrenic nerves [1]. - The esophagus passes **posterior** to this compartment, not through it. *Superior* - The **superior mediastinum** extends from the thoracic inlet to the level of the sternal angle (T4/T5). - It contains large vessels like the **aortic arch** and its branches, the SVC, trachea, and thymus [1]. - While the **uppermost part of the thoracic esophagus** does pass through the superior mediastinum, this represents only a small portion of its total length.

Q: Which of the following lipoproteins is most strongly associated with an increased risk of cardiovascular diseases and is commonly referred to as "bad cholesterol"?

LDL. ***LDL*** - **Low-density lipoprotein (LDL)** is commonly referred to as "bad" cholesterol because elevated levels are the **primary driver** of atherosclerotic plaque buildup in arterial walls. - LDL particles transport cholesterol from the liver to peripheral tissues; when present in excess, they infiltrate the arterial intima and undergo oxidative modification, triggering inflammatory responses that lead to atherosclerosis. - **Clinical significance:** LDL cholesterol is the primary target of lipid-lowering therapy in cardiovascular disease prevention. *VLDL* - **Very low-density lipoprotein (VLDL)** primarily transports endogenously synthesized **triglycerides** from the liver to peripheral tissues. - While elevated VLDL levels do contribute to cardiovascular risk (particularly through conversion to small, dense LDL particles), it is not the primary lipoprotein targeted in cardiovascular risk assessment. *Chylomicron* - **Chylomicrons** transport **dietary lipids** (triglycerides and cholesterol) from the intestines to tissues after meals. - They are rapidly cleared from circulation (half-life of 5-10 minutes) and are typically not present during fasting, making their contribution to chronic atherosclerotic plaque formation minimal. *Lp(a)* - **Lipoprotein(a) [Lp(a)]** is structurally similar to LDL but contains an additional apolipoprotein(a) molecule, which has homology to plasminogen and may interfere with fibrinolysis. - While Lp(a) is an independent cardiovascular risk factor, it is less commonly measured in routine clinical practice, and **LDL remains the cornerstone lipoprotein** for cardiovascular risk stratification and management.

Q: What is the half-life of Prealbumin?

2 days. ***2 days*** - Prealbumin, also known as transthyretin, has a **short half-life** of approximately 2-3 days, making it a sensitive indicator of recent changes in **nutritional status**. - Its rapid turnover allows for prompt reflection of improvement or deterioration in protein synthesis. *10 days* - A half-life of 10 days would make prealbumin less responsive to acute changes in nutrition compared to its actual turnover rate. - This duration is longer than the typical half-life of proteins used to monitor **short-term nutritional status**. *20 days* - A 20-day half-life would indicate a protein with a much slower turnover, unsuitable for monitoring **acute nutritional interventions**. - Proteins with such long half-lives, like **albumin**, reflect more chronic states rather than rapid changes. *40 days* - A half-life of 40 days is characteristic of proteins like **albumin**, which are influenced by longer-term nutritional and inflammatory processes. - Such a long half-life would not be useful for assessing immediate responses to **nutritional support** or acute disease states.

Q: Glucagon stimulates

Gluconeogenesis. ***Gluconeogenesis*** - **Glucagon** is a hormone that primarily acts to raise **blood glucose levels** by stimulating the production of glucose from non-carbohydrate sources. - This process, **gluconeogenesis**, occurs mainly in the liver and is initiated by glucagon to counteract hypoglycemia. *Glycogenesis* - **Glycogenesis** is the process of synthesizing **glycogen** from glucose and is primarily stimulated by insulin when blood glucose levels are high. - Glucagon's role is to *inhibit* glycogen synthesis and instead promote glycogen breakdown. *Fatty acid synthesis* - **Fatty acid synthesis** is an anabolic process that primarily occurs when there is an excess of energy and glucose, often stimulated by **insulin**. - Glucagon generally has an **inhibitory effect** on fatty acid synthesis, as its main goal is to mobilize energy stores, not create them. *Glycolysis* - **Glycolysis** is the breakdown of glucose to produce energy, and it is stimulated when glucose is abundant and energy is needed. - Glucagon primarily acts to *inhibit* glycolysis in the liver, thereby conserving glucose for use by other tissues and promoting its release into the bloodstream.

Q: Carboxypeptidase contains which mineral?

Zinc. ***Zinc*** - **Carboxypeptidase** is a **metalloenzyme**, meaning it requires a metal ion for its catalytic activity. - **Zinc** acts as a crucial cofactor in the active site of carboxypeptidase, enabling its proteolytic function. *Copper* - **Copper** is a component of enzymes like **cytochrome c oxidase** and **superoxide dismutase**, but not carboxypeptidase. - Its presence is essential for processes like **electron transport** and **antioxidant defense**. *Iron* - **Iron** is a central component of **hemoglobin** and **myoglobin** for oxygen transport, and in enzymes like **catalase** and **peroxidase**. - It is not involved in the catalytic mechanism of carboxypeptidase. *None of the options* - This option is incorrect because **Zinc** is a known and essential mineral for the function of carboxypeptidase. - Carboxypeptidase is a metalloenzyme, and a metal cofactor is required for its activity.

Q: HLA is located on ?

Short arm of chr-6. ***Short arm of chr-6*** - The **Human Leukocyte Antigen (HLA)** complex, crucial for immune recognition, is located on the **short arm of chromosome 6**. [1] - This region, specifically 6p21.3, contains highly polymorphic genes encoding MHC (Major Histocompatibility Complex) proteins. [2] *Long arm of chr-6* - The **long arm of chromosome 6** contains many genes, but the primary HLA complex is not located here. - Genes on the long arm are involved in various cellular functions, but not central to immune recognition via HLA. *Short arm of chr-3* - Genes on **chromosome 3**, including its short arm, are not associated with the primary HLA complex. - Chromosome 3 is known for genes related to conditions such as von Hippel-Lindau disease. *Long arm of chr-3* - The **long arm of chromosome 3** is not the location for the HLA complex. - This region contains genes involved in diverse cellular processes and disease associations, but not immune recognition via HLA molecules. **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 55-56. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of the Immune System, pp. 239-240.

Q: Which of the following statements about Polycythemia vera is false?

Increased LAP score. ***Decrease LAP score*** - In polycythemia vera, the **LAP (leukocyte alkaline phosphatase) score** is typically increased, indicating more mature leukocytes. - A **decrease in LAP score** is not consistent with the disease, making this statement incorrect. *Increased platelets* - Polycythemia vera often results in **thrombocytosis**, characterized by increased platelet counts [1]. - This is a common feature of the disorder, reflecting overproduction of blood cells in the bone marrow. *Leucocytosis* - Patients with polycythemia vera frequently exhibit **leucocytosis**, or increased white blood cell counts, due to hypercellularity of the bone marrow [1]. - This is an important aspect of the disease, often seen alongside increases in red blood cells and platelets. *Increased vit B12* - An elevation in **vitamin B12** levels can occur in polycythemia vera, often due to increased binding proteins. - This is a well-recognized phenomenon associated with the increased cell turnover in this condition. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of White Blood Cells, Lymph Nodes, Spleen, and Thymus, pp. 626-627.

Q: What is the mechanism of metabolism for alcohol, aspirin, and phenytoin at high doses?

Zero order kinetics. ***Zero order kinetics*** - This mechanism occurs when the **metabolic enzymes become saturated at high drug concentrations**, leading to a constant amount (not a constant percentage) of drug being eliminated per unit time. - Alcohol, aspirin, and phenytoin are examples of drugs that exhibit **saturable metabolism**, transitioning from first-order to zero-order kinetics at higher doses. *First pass kinetics* - This describes the **metabolism of a drug by the liver or gut wall enzymes before it reaches systemic circulation** after oral administration. - While relevant to the oral bioavailability of these drugs, it does not describe the specific mechanism of elimination at high doses. *First order kinetics* - In this mechanism, a **constant fraction or percentage of the drug is eliminated per unit of time**, meaning the rate of elimination is directly proportional to the drug concentration. - Most drugs follow first-order kinetics at therapeutic doses because metabolizing enzymes are not saturated. *Second order kinetics* - This is a **less common pharmacokinetic model** where the rate of elimination is proportional to the square of the drug concentration or involves two reactants. - It does not typically describe the common elimination patterns of most drugs, including alcohol, aspirin, and phenytoin.

Q: What is the critical closing pressure in the context of capillary physiology?

Pressure below which capillaries close. ***Pressure below which capillaries close*** - The **critical closing pressure** is the lowest pressure at which blood can flow through a capillary. - When the luminal pressure falls below this threshold, the capillary collapses due to **extrinsic tissue pressure** and intrinsic vascular tone. *Arterial pressure minus venous pressure* - This calculation represents the **arteriovenous pressure gradient**, which drives blood flow through a vascular bed. - It does not directly define the point at which capillaries collapse. *Capillary pressure minus venous pressure* - This difference primarily influences filtration and reabsorption of fluids across the capillary wall. - It is not directly related to the **critical closing pressure** of the capillaries. *None of the options* - This is incorrect as one of the provided options accurately defines the **critical closing pressure**.

Question 1

Esophagus is present in which mediastinum?

Accepted Answer

Posterior

Answer

Answer

Middle

Answer

Superior

Question 2

Which of the following lipoproteins is most strongly associated with an increased risk of cardiovascular diseases and is commonly referred to as "bad cholesterol"?

Accepted Answer

LDL

Answer

VLDL

Answer

Chylomicron

Answer

Lp (a)

Question 3

What is the half-life of Prealbumin?

Accepted Answer

2 days

Answer

10 days

Answer

20 days

Answer

40 days

Question 4

Glucagon stimulates

Accepted Answer

Gluconeogenesis

Answer

Glycogenesis

Answer

Fatty acid synthesis

Answer

Glycolysis

Question 5

Carboxypeptidase contains which mineral?

Accepted Answer

Zinc

Answer

Copper

Answer

Iron

Answer

None of the options

Question 6

HLA is located on ?

Accepted Answer

Short arm of chr-6

Answer

Long arm of chr-6

Answer

Short arm of chr-3

Answer

Long arm of chr-3

Question 7

Which of the following statements about Polycythemia vera is false?

Accepted Answer

Increased LAP score

Answer

Increased vitamin B12 levels

Answer

Leukocytosis is present

Answer

Increased platelet count

Question 8

What is the sequence of events in acute inflammation?

Accepted Answer

Transient vasoconstriction - Vasodilatation - Increased permeability - Stasis

Answer

Transient vasoconstriction - Stasis - Vasodilatation - Increased permeability

Answer

Transient vasoconstriction - Vasodilatation - Stasis - Increased permeability

Answer

Vasodilatation - Stasis - Transient vasoconstriction - Increased permeability

Question 9

What is the mechanism of metabolism for alcohol, aspirin, and phenytoin at high doses?

Accepted Answer

Zero order kinetics

Answer

First pass kinetics

Answer

First order kinetics

Answer

Second order kinetics

Question 10

What is the critical closing pressure in the context of capillary physiology?

Accepted Answer

Pressure below which capillaries close

Answer

Arterial pressure minus venous pressure

Answer

Capillary pressure minus venous pressure

Answer

None of the options

NEET-PG 2013

Anatomy

Biochemistry

Pathology

Pharmacology

Physiology